ArticleTransplantation and cellular therapy2025

Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group.

Nikolaos Katsivelos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.